These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16784405)

  • 1. Olanzapine: a 5-year perspective.
    Littrell KH; Petty RG; Wolf NM
    Expert Rev Neurother; 2006 Jun; 6(6):811-21. PubMed ID: 16784405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of olanzapine use in adolescents.
    Schulz C; Haight RJ
    Expert Opin Drug Saf; 2013 Sep; 12(5):777-82. PubMed ID: 23876012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Olanzapine].
    Wittköpper K; El-Armouche A; Eschenhagen T
    Dtsch Med Wochenschr; 2008 Sep; 133(39):1958-62. PubMed ID: 18798132
    [No Abstract]   [Full Text] [Related]  

  • 4. Obsessive-compulsive symptoms with olanzapine.
    Alevizos B; Papageorgiou C; Christodoulou GN
    Int J Neuropsychopharmacol; 2004 Sep; 7(3):375-7. PubMed ID: 15231024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Olanzapine].
    Nagai N; Watanabe K
    Nihon Rinsho; 2013 Apr; 71(4):666-72. PubMed ID: 23678597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.
    Citrome L; Holt RI; Walker DJ; Hoffmann VP
    Clin Drug Investig; 2011; 31(7):455-82. PubMed ID: 21495734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine for the treatment of bipolar disorder in children and adolescents.
    Strawn JR; Delbello MP
    Expert Opin Pharmacother; 2008 Feb; 9(3):467-74. PubMed ID: 18220496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness criterion: balancing efficacy against the risks of weight gain.
    Citrome L
    J Clin Psychiatry; 2007; 68 Suppl 12():12-7. PubMed ID: 17956151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Olanzapine in the treatment of bipolar disorder].
    Krüger S
    Psychiatr Prax; 2006 Mar; 33 Suppl 1():S18-26. PubMed ID: 16511727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Economic analyses of olanzapine in the treatment of schizophrenia and bipolar disorder].
    Dilla T; Prieto L; Ciudad A; Sacristán JA
    Actas Esp Psiquiatr; 2004; 32(5):269-79. PubMed ID: 15529211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia.
    Kulkarni G; Narayanaswamy JC; Math SB
    Indian J Pharmacol; 2012; 44(5):649-50. PubMed ID: 23112432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics: newer options for mania and maintenance therapy.
    Vieta E; Goikolea JM
    Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine - relapse prevention following mania.
    Dando S; Tohen M
    J Psychopharmacol; 2006 Mar; 20(2 Suppl):31-8. PubMed ID: 16551670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of olanzapine in the treatment of bipolar I disorder.
    Lieberman DZ; Goodwin FK
    Expert Rev Neurother; 2004 Sep; 4(5):759-67. PubMed ID: 15853503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
    BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine treatment of eight adolescent patients with psychosis.
    Ercan ES; Kutlu A; Varan A; Cikoğlu S; Coşkunol H; Bayraktar E
    Hum Psychopharmacol; 2004 Jan; 19(1):53-6. PubMed ID: 14716713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns.
    McClellan JM
    Am J Psychiatry; 2007 Oct; 164(10):1462-4. PubMed ID: 17898331
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of the evidence for the use of antipsychotics in the maintenance treatment of bipolar disorders.
    Hellewell JS
    J Psychopharmacol; 2006 Mar; 20(2 Suppl):39-45. PubMed ID: 16551671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antipsychotics in bipolar and schizoaffective mania.
    Mensink GJ; Slooff CJ
    Acta Psychiatr Scand; 2004 Jun; 109(6):405-19. PubMed ID: 15117285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.